RGNX 8-K 2026-09-23

REGENXBIO Inc. (RGNX) 8-K dated 2026-09-23 — accession 0001193125-26-399377. This URL is the filing, not the RGNX hub.

REGENXBIO Inc. (RGNX) is a biotechnology company listed on US.

REGENXBIO Inc. filed a 8-K on 2026-09-23. Accession 0001193125-26-399377.

Cached items: 1.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported RGNX revenue for 2025-12-31 was $170.4M. Net income was -$193.9M. Revenue was up 104.5% from 2024-12-31 to 2025-12-31. RGNX currently screens at market cap $440.4M.

Not investment advice. The RGNX SEC hub lists recent forms. The stock page is the research view.